TrialBlood neoplasia2025

Outcomes of myeloablative allogeneic hematopoietic cell transplantation with omidubicel vs alternative donor sources.

Chenyu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.